Dabsyl chloride (4-dimethylaminoazobenzene-4'-sulfonyl chloride) is a useful chromophoric labeling reagent for amino acids (1, 2) . It reacts readily with all amino acids to form dabsyl amino acids, which can be seen on a thin-layer chromatographic plate and are photostable. The sensitivity of dabsyl chloride is about 60-fold that of 2,4-dinitrofluorobenzene, but about fivefold less than that of dansyl chloride; on the other hand, the stability and visibility of dabsyl amino acids on a thin-layer chromatographic plate are superior to that of either dansyl-or 2,4-dinitrophenyl-labeled amino acids (2) .
Recently, we reported the use of dabsyl chloride and thinlayer chromatography on silica gel plates for the evaluation of urinary amino acids in various diseases (2) . Our preliminary results indicated that high amounts of tryptophan and glycine occur in the urine of patients with chronic myeloblastic leukemia, acute myeloblastic leukemia, and lymphosarcoma. To assess the biological significance of the increases of these amino acids, we made further quantitative analyses of more urine samples. In doing so, we found that the combination of dabsylation and thin-layer chromatographic procedure was quite satisfactory for qualitative detection, but was quite tedious for quantitative determination of urinary amino acids.
During Hospital. All urine samples were stored at -30 #{176}C for two to six weeks before use.
Dabsylation
Place 0.5 mL of urine, 0.5 mL of 0.5 molfL sodium bicarbonate, and 2 mL of dabsyl chloride (2 g/L, in acetone) into a 15-mL glass tube; the final pH of this mixture should be 8. Figure 1 , a representative chromatogram, shows the sharp, distinct peaks produced by the hydrolyzed product, 4-dimethylaminoazobenzene-4'-sulfonic acid, and by labeled glycine, methionine, valine, tryptophan, and phenylalanine; retention times were 3.6, 6.5, 11.7, 15.5, 17.5, and 21.3 mm, respectively.
Results

Separation of Dabsyl Amino Acids
Leucine and isoleucine somewhat overlap in this system.
The highly polar amino acids such as glutamic acid, aspartic acid, threonine, and serine will come out together right after the void volume; the basic amino acids such as lysine and arginine will stay on the column and can be eluted with increased concentrations of ethanol.
Analytical Variables
Linearity and sensitivity. of glycine added to six aged urine samples (0.1 mg added to 0.2 mL) was 60-70%; however, the mean analytical recovery of glycine added to eight fresh samples (0.105mg added to 0.2 mL) was 99%, the range 96 to 103%. The ammonia and other amino compounds produced in the aged urine samples could affect the recovery of the amino acid by competing for the available dabsyl chloride. When the ammonia was removed by lyophilizing the specimen, the recovery of amino acid added to urine improved remarkably (80-90%). The mean analytical recovery of tryptophan added to six fresh urine samples (87 zg to 0.2 mL) was 96%, the range 94 to 98%.
Precision.
We assessed within-run precision of the assay by processing aliquots of dabsylated glycine solution through the procedure during a single day. The coefficients of variation (CVs) were 5.9% at 33 mg/L (n = 10), 6.0% at 11 mg/L (n = 10), and 2.4% at 2.75 mg/L (n = 8). Day-to-day precision was checked during three weeks. The CVs were 5.2% at 33 mg/L (n = 14), 6.4% at 11 mg/L (n = 16), and 7.6% at 2.75 mg/L (n = 13).
Analysis of Urine Sample
Urine samples from 90 cancer patients and 12 ostensibly normal subjects were dabsylated and analyzed by the described procedure. Figure 3B , the chromatogram of a urine sample from a normal subject, demonstrates peaks for glycine and ammonia. The chromatograni in Figure 3A demonstrates the presence of glycine, ammonia, and tryptophan in a urine sample of cancer patient.
The presence of glycine and tryptophan in the urine sample has been confirmed by two-dimensional thin-layer chromatography of their dabsylated derivatives on silica-gel plates (2). All normal and patients' urine samples contained detectable glycine (Table 1) , with no significant difference between samples from normal subjects and cancer patients. The range for each group was quite large.
Chromatograms of most urine samples from malignantdisease patients showed a peak behaving like tryptophan ( 
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Detection of Urinary Phenylalanine in Phenylketonuria
A urine sample from a phenylketonuric patient was dabsylated and analyzed as described. Figure 4A illustrates the presence of phenylalanine (0.6 gIL) in the patient's urine, as was further confirmed by co-chromatography of the dabsylated urine sample with dabsyl-phenylalanine ( Figure 4B ). Under the same experimental conditions, no phenylalanine was detected in normal urine ( Figure 3B) . Evidently, our procedure is a rapid and suitable one for detecting phenylketonuria.
Discussion
In the present method we made use of the newly developed reagent, dabsyl chloride, to label amino acids. The dabsyllabeled amino acids have maximum absorbance near 425 nm. Thus amino acids in urine samples are easily measured in the visible region, and interferences caused by ultraviolet-absorbing compounds in urine are avoided.
The appreciable amount of ammonia in urine interferes with the determination of methionine and valine. Ammonia reacts with dabsyl chloride to form dabsylainide, which has the same retention time (11.7 mm) as that of dabsyl methionine (cf. Figures 1 and 3A) . Because the ammonia may consume so much dabsyl chloride that it seriously interferes with the dabsylation of amino acids in the urine samples, it is advisable to remove ammonia by lyophilizing urine samples at pH 8.9 before dabsylation, particularly if the urine specimen has been stored long.
Mean values for urinary glycine and tryptophan of normal subjects are reportedly (3) about 100 and 13 mgIL of urine, respectively-very close to our data (60 and 12.4 mgIL). This seems to be the first time that high urinary tryptophan has been noted in most cancer patients.
As has been commonly observed, many cancer patients lose a significant fraction of their stable proteins; the mechanism of the loss is unknown (4) . The growth of cancer leads to profound alterations of organs and functions, a consequence of multiple interactions between destruction, attempted repair, homeostasis, and production of biochemical toxins by the tumor. The overall result is the widely recognized, although poorly understood, syndrome known as cachexia (5) . It is common to think of tumors as one-way nitrogen traps and to infer that nutritional consequences of tumor growth on the host are dominated by this irreversible step (4) . If this is the case, the tumor seems to have a peculiar capability to capture protein molecules from the host tissues. Most amino acids liberated from the captured protein may be utilized by the tumor cells, and a few amino acids such as tryptophan may be excreted in the urine, as demonstrated in the present study; however, the reason that only tryptophan is increased is unknown. With the present method we can identify phenylketonuria in 52 mm. In this study, of 102 samples analyzed, none showed urinary phenylalanine, but analysis of phenylketonuric urine showed urinary phenylalanine unequivocally ( Figure 4A ). Other inborn-errors of metabolism characterized by aminoaciduria (6) such as maple-syrup urine disease (7) Efron et al. (16) . Their procedure involves four color reagents and overnight chromatographic development and is quite tedious. Our method appears to be more sensitive, faster, and simpler for this kind of screening.
Other mobile phases than the one used in this study also gave good results: methanol/water (4/6 by vol) or methanol! sodium acetate buffer (4/6). Furthermore, the methanol systems could operate at 1 mL/min with a lower column pressure (less than 6.9 MPa). 
